on shore manufacturing of medications
2026 · 1st Quarter (Jan 1 - Mar 31)
EXELA PHARMA SCIENCES, LLC
Filed by OLD NORTH STRATEGIES, LLC.
Open official filingSource-reported fields
Filing overview
- Type
- 1st Quarter - Report
- Posted
- Apr 30, 2026
- Income
- $27,000.00
- Expenses
- Not reported
- Registrant
- OLD NORTH STRATEGIES, LLC
- Filing UUID
- 90ee56aa-3987-4a03-ae62-7a4ad671fada
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
on shoring medications
R&D of meds
on shore medications
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.